Commentary

Article

State of the Science Summit - Hematologic Malignancies: Chaired by Veronika Bachanova, MD, PhD, and Jeffrey Miller, MD

State of the Science Summit - Hematologic Malignancies: Chaired by Veronika Bachanova, MD, PhD, and Jeffrey Miller, MD

State of the Science Summit - Hematologic Malignancies: Chaired by Veronika Bachanova, MD, PhD, and Jeffrey Miller, MD

Speakers

  • Jeremy Allred, MD | Masonic Cancer Center
  • Joseph Maakaron, MD | Masonic Cancer Center
  • Marie Hu, MD | Masonic Cancer Center
  • Craig Eckfeldt, MD, PhD | Masonic Cancer Center
  • Daniel O'Leary, MD | Masonic Cancer Center
  • Mark Juckett, MD, MHCM | Masonic Cancer Center
  • Sanjal Desai, MD | Masonic Cancer Center

Topics

  • Current and Emerging Treatment Standards for Myelodysplastic Syndrome
  • Debate! Bispecific Antibodies vs CAR T in R/R DLBCL
  • Treatment Crossroads: How do you sequence bispecifics and CAR T in Myeloma?
  • Emerging Agents in R/R AML
  • Sequencing Therapies in CLL

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Michael R. Grunwald, MD, FACP
Shella Saint Fleur-Lominy, MD, PhD
Manali Kamdar, MD
Matthew Matasar, MD, chief, Division of Blood Disorders, Rutgers Cancer Institute; professor, medicine, Rutgers Robert Wood Johnson Medical School
Sattva S. Neelapu, MD
Sattva S. Neelapu, MD
Julie M. Vose, MD, MBA
Lakshmi Nayak, MD
John Burke, MD
Timothy Hughes, MD, MBBS, FRACP, FRCPA